Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients

NCT01325935 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1187

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Clopidogrel

Sponsor

Associations for Establishment of Evidence in Interventions

Collaborators

[object Object]